Cornercap Investment Counsel Inc Immuno Gen, Inc. Transaction History

Cornercap Investment Counsel Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$3.67 - $4.92 $63,292 - $84,850	17,246 Added 47.82%	53,313 $204,000
Q4 2022 Feb 13, 2023	BUY	$4.55 - $6.31 $1,064 - $1,476	234 Added 0.65%	36,067 $178,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $367 - $530	82 Added 0.23%	35,833 $171,000
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $112,615 - $205,925	35,751 New	35,751 $161,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.